The public registers hold a second record for Viatris. The fuller profile, with 0 active US DMFs and 3 valid CEPs, is at Viatris. Figures on this page cover only this record.
Viatris is a finished-dose manufacturer based in United States. It appears in 3,635 regulatory filings across 10 regulators, without an active US DMF or CEP on file. Its filings concentrate with MEDSAFE (NZ), EMA and AIFA (IT). Its GMP standing is certified by HSA (SG).
| Regulator | Filings | GMP certificates |
|---|---|---|
| MEDSAFE (NZ) | 848 | None |
| EMA | 624 | None |
| AIFA (IT) | 585 | None |
| INFARMED (PT) | 524 | None |
| FAMHP (BE) | 505 | None |
| MPA (SE) | 344 | None |
| HSA (SG) | None | 2 |
Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Viatris comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.